Get An Overview and Updates on Atrial Fibrillation

OSUWexnerbloglogo2014 Get An Overview and Updates on Atrial Fibrillation. To discuss in more depth the most common sustained arrhythmia, Atrial fibrillation, and the updates in management are two of Ohio State University’s cardiology experts. We’re pleased to introduce Assistant Professor of Cardiology Dr. Jim Liu and Assistant Professor of Cardiology Dr. Salvatore Savona. Jim is a noninvasive cardiologist and he will take us through presentation, evaluation, risk factor management and stroke prevention of Afib. And Sal is an Electrophysiologist. His discussion will focus on rate and rhythm control strategies.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Recognize risk factors for atrial fibrillation
  • Understand options for stroke prevention in atrial fibrillation
  • Understand differences in rate and rhythm control strategies for management.
  • Review the role of catheter ablation in the management of atrial fibrillation.

You’ll also learn about the following:

  • Atrial Fibrillation Epidemiology
  • AF Burden
  • Anticoagulation in Women

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Get An Update on Antibiotics on CME Webcast

OSUWexnerbloglogo2014 Get An Update on Antibiotics on CME Webcast. Today on OSU MedNet, we are going to update you on some of these new antibiotics. Let me welcome today’s guest, Dr. Sydney Agnello. She is an infectious disease expert and Assistant Professor of Internal Medicine from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: enhance knowledge of clinical use of well-known antibiotics; and enhance understanding of newer antibiotics available and when they may be used clinically.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Experts Provide An Update on Treatment of COVID-19

OSUWexnerbloglogo2014 Experts Provide An Update on Treatment of COVID-19. The pandemic is bad now but it is projected to get even worse over the next months. Many physicians, nurse practitioners, and physician assistants are going to be called on to care for patients with COVID-19 and we want to be sure that you have to tools you need to provide the best possible care for your patients. On this CME webcast, welcome back to MedNet21 two veteran presenters about the COVID-19 outbreak. Dr. Michael Haden is an Assistant Professor of Internal Medicine from the Division of Infectious Disease at the Ohio State University. And Dr. Rachel Quaney is a pulmonologist and Clinical Instructor of Internal Medicine at Ohio State.


What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW infection control measures necessary regarding SARS-CoV-2; PROVIDE update on current treatment recommendations for COVID-19; EVALUATE a patient with respiratory failure from COVID-19; and DISCUSS the risk factors for SARS-CoV-2 transmission as well as the risk factors for severe COVID-19.

You’ll also learn about the following:

  • Improvements in the treatment of COVID-19
  • Changes in the ICU management of COVID-19
  • COVID-19 vaccine safety

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides An Update on COPD

OSUWexnerbloglogo2014 CME Webcast Provides An Update on COPD. This webcast will give you opportunity learn a great deal about COPD from an our expert that manages it on a regular basis.

 

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: Diagnose and classify COPD; Prescribe step-wise treatment for management of stable COPD; Identify patients who would benefit by home oxygen; Manage COPD exacerbations; and Develop strategies to reduce re-admissions for COPD.

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

How to Add An Affiliation for Enduring Materials

OSUWexnerbloglogo2014This tutorial teaches how to add an affiliation for Enduring Materials.  When you add an affiliation, you’re simply adding the hospital that you’re connected with inside the Hospital Affiliation section of your account on our website.  This is because your hospital has paid to give you “free” access to our enduring materials post-test.  However, you can only get access if you add the affiliation to your account.  Instead of paying $25, you won’t be asked to make a payment.

Note: First, create an account on our OSU CCME website before starting the tutorial.

Let’s get started with the tutorial.

Click on the orange”My Account” tab at the top right of your screen

 

Click on the Hospital Affiliations button.

 

At the Drop-down Menu select your hospital name or the name you’re using for your affiliation.

 

Once you choose your Hospital Affiliation, Waiting will appear in the Status column.  The Waiting status will appear until your affiliation is approved by the Administrator. If you attempt to take a post-test in the Waiting status, you’ll see a web page dialog to make a payment.  Please wait until you are approved.

When your account gets approved, Approved will appear in the Status column.

You will also receive an e-mail, similar to the e-mail above, once your account is approved.